Jansson JH - Search Results

1

Lind M, Jansson JH. Lind M, et al. Among authors: jansson jh. Lakartidningen. 2006 Mar 29-Apr 4;103(13):1031-4. Lakartidningen. 2006. PMID: 16646221 Swedish. No abstract available.

2

Thrombomodulin as a marker for bleeding complications during warfarin treatment.

Lind M, Boman K, Johansson L, Nilsson TK, Ohlin AK, Birgander LS, Jansson JH. Lind M, et al. Among authors: jansson jh. Arch Intern Med. 2009 Jul 13;169(13):1210-5. doi: 10.1001/archinternmed.2009.170. Arch Intern Med. 2009. PMID: 19597070

3

Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.

Lind M, Jansson JH, Nilsson TK, Järvholm LS, Johansson L. Lind M, et al. Among authors: jansson jh. Thromb Res. 2013 Aug;132(2):e77-82. doi: 10.1016/j.thromres.2013.06.011. Epub 2013 Jul 5. Thromb Res. 2013. PMID: 23834818

4

Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.

Johansson M, Lind M, Jansson JH, Fhärm E, Johansson L. Johansson M, et al. Among authors: jansson jh. Thromb Res. 2018 May;165:86-94. doi: 10.1016/j.thromres.2018.03.015. Epub 2018 Mar 27. Thromb Res. 2018. PMID: 29604434

5

Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries.

Öhman L, Johansson M, Jansson JH, Lind M, Johansson L. Öhman L, et al. Among authors: jansson jh. Clin Epidemiol. 2018 Sep 17;10:1215-1221. doi: 10.2147/CLEP.S177058. eCollection 2018. Clin Epidemiol. 2018. PMID: 30271217 Free PMC article.

6

von Willebrand activation factor as a marker of mortality, cardiovascular events, and bleeding complications in patients treated with oral anticoagulants.

Lind M, Johansson L, Nilsson TK, Jansson JH, Hollestelle MJ. Lind M, et al. Among authors: jansson jh. Thromb Res. 2015 Nov;136(5):878-82. doi: 10.1016/j.thromres.2015.08.016. Epub 2015 Aug 28. Thromb Res. 2015. PMID: 26364970

7

D-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment.

Lind M, Boman K, Johansson L, Nilsson TK, Järvholm LS, Jansson JH. Lind M, et al. Among authors: jansson jh. Clin Biochem. 2014 May;47(7-8):570-3. doi: 10.1016/j.clinbiochem.2014.03.003. Epub 2014 Mar 15. Clin Biochem. 2014. PMID: 24636802

8

Phosphatidylethanol Levels, As a Marker of Alcohol Consumption, Are Associated With Risk of Intracerebral Hemorrhage.

Johansson K, Johansson L, Pennlert J, Söderberg S, Jansson JH, Lind MM. Johansson K, et al. Among authors: jansson jh. Stroke. 2020 Jul;51(7):2148-2152. doi: 10.1161/STROKEAHA.120.029630. Epub 2020 Jun 16. Stroke. 2020. PMID: 32543974 Free article.

9

[Central venous catheter and malignant disease. The value of thrombosis prophylaxis is questioned now].

Jansson JH. Jansson JH. Lakartidningen. 2005 Jun 27-Jul 10;102(26-27):1984-5. Lakartidningen. 2005. PMID: 16044753 Swedish. No abstract available.

10

Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.

Johansson K, Jansson JH, Johansson L, Bylesjö I, Nilsson TK, Eliasson M, Söderberg S, Lind M. Johansson K, et al. Among authors: jansson jh. Cerebrovasc Dis Extra. 2017;7(1):84-94. doi: 10.1159/000468994. Epub 2017 Apr 21. Cerebrovasc Dis Extra. 2017. PMID: 28433996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page